Form 4: DENTSPLY SIRONA CFO Increases Stake Through Routine RSU Dividend Acquisition

DENTSPLY SIRONA's EVP & CFO, Matthew E. Garth, acquired 432.121 additional restricted stock units as dividends on existing awards, increasing his total beneficial ownership to 43,455.121 shares.

Summary

• Matthew E. Garth, the Executive Vice President and Chief Financial Officer of DENTSPLY SIRONA Inc. (XRAY), reported an acquisition of common stock.
• The transaction occurred on July 11, 2025, and involved the acquisition of 432.121 shares of Common Stock.
• This acquisition represents dividends on previously awarded restricted stock units (RSUs), issued in the form of additional RSUs.
• The newly acquired RSUs are subject to the same vesting terms as the underlying awards and vest simultaneously.
• Each restricted stock unit converts to common stock on a 1:1 basis.
• Following this transaction, Matthew E. Garth's total beneficial ownership of DENTSPLY SIRONA Common Stock stands at 43,455.121 shares.

Sentiment

Score: 7

Explanation: The transaction is a routine acquisition of restricted stock units as dividends, indicating ongoing executive compensation and alignment of management interests with shareholders, which is generally a neutral to slightly positive signal.

Positives

• The acquisition of additional restricted stock units by a key executive, even through dividends, indicates continued participation in the company's equity compensation plan, aligning management's interests with those of shareholders.
• The transaction is a routine part of executive compensation, reflecting a stable and expected process for equity awards.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing, as it primarily reports a past transaction related to executive compensation.

Management Comments

• Matthew E. Garth, EVP & CFO, acquired additional restricted stock units as part of a dividend distribution on existing awards, indicating ongoing participation in the company's equity compensation plan.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation, which is a standard practice across industries to align management incentives with shareholder interests. It does not reflect broader industry trends or competitive shifts.

Comparison to Industry Standards

• Not applicable, as this Form 4 reports a routine executive compensation event (RSU dividend) rather than operational or financial performance metrics that would be benchmarked against industry peers or specific comparable companies/projects.

Related Party Transactions

• This filing reports an acquisition of securities by an executive as part of their compensation, which is a standard insider transaction and not typically categorized as a related party transaction involving special terms or conflicts of interest.

Stakeholder Impact

• Shareholders: The transaction aligns the interests of a key executive with shareholders through equity ownership, potentially fostering long-term value creation.
• Employees: This is a specific executive compensation event and does not directly impact the broader employee base beyond general compensation practices.

Next Steps

• The acquired restricted stock units will vest according to the same terms as the underlying awards to which they relate.

Key Dates

Recommendation

Keywords

DENTSPLY SIRONA, XRAY, Form 4, insider transaction, restricted stock units, RSU, executive compensation, dividend, common stock, Matthew E. Garth